Search results for "Real word"

showing 2 items of 2 documents

Doesdarknesslead tohappiness? Masked suffix priming effects

2008

Masked affix priming effects have usually been obtained for words sharing the initial affix (e.g., re action- RE FORM). However, prior evidence on masked suffix priming effects (e.g., bak er -WALK ER ) is inconclusive. In the present series of masked priming lexical decision experiments, a target word was briefly preceded by a morphologically or orthographically related prime, or by an unrelated prime. In Experiment 1, the prime words in the suffix priming condition were formed by their suffixes (e.g., er -WALK ER ). In Experiment 2, the primes included the suffix inserted in a nonsense symbol string (e.g., %%%% er -WALK ER ). In Experiment 3, the primes were formed by a real word that shar…

Linguistics and LanguageDissociation (neuropsychology)Speech recognitionAffixExperimental and Cognitive PsychologyLanguage and LinguisticsEducationSymbol stringDarknessWord recognitionLexical decision taskReal wordSuffixPsychologyLanguage and Cognitive Processes
researchProduct

Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multi…

2018

BACKGROUND: The aim of the study was to evaluate the achievement of 'no evidence of disease activity' (NEDA) over a 12-month period in a large multicenter population with relapsing remitting multiple sclerosis (RRMS) treated with delayed-release dimethyl fumarate (DMF) and teriflunomide (TRF) using a propensity-score adjustment. METHODS: A time-to-event method was used to determine the percentages of patients with RRMS (pwRRMS) in both groups achieving NEDA 3 (no relapses, no 12-week confirmed disability progression, and no new T2/gadolinium-enhancing brain lesions). We described the safety profile of the investigated drugs. RESULTS: Of the 587 pwRRMS treated with DMF and the 316 pwRRMS tre…

safetymedicine.medical_specialtydimethyl fumarate; efficacy; no evidence of disease activity 3; safety; teriflunomide; pharmacology; neurology; neurology (clinical)Populationefficacylcsh:RC346-429Disease activity03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineTeriflunomideteriflunomideMedicine030212 general & internal medicineno evidence of disease activity 3educationlcsh:Neurology. Diseases of the nervous systemOriginal ResearchPharmacologyeducation.field_of_studydimethyl fumarateDimethyl fumaratebusiness.industryMultiple sclerosismedicine.diseasechemistryRelapsing remittingNeurologySettore MED/26 - NeurologiaReal wordNeurology (clinical)business030217 neurology & neurosurgerydimethyl fumarate; efficacy; no evidence of disease activity 3; safety; teriflunomide
researchProduct